ES8503372A1 - Procedimiento para preparar un plasmido - Google Patents

Procedimiento para preparar un plasmido

Info

Publication number
ES8503372A1
ES8503372A1 ES533197A ES533197A ES8503372A1 ES 8503372 A1 ES8503372 A1 ES 8503372A1 ES 533197 A ES533197 A ES 533197A ES 533197 A ES533197 A ES 533197A ES 8503372 A1 ES8503372 A1 ES 8503372A1
Authority
ES
Spain
Prior art keywords
sequences
prokaryotes
preparation
gene products
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533197A
Other languages
English (en)
Other versions
ES533197A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of ES533197A0 publication Critical patent/ES533197A0/es
Publication of ES8503372A1 publication Critical patent/ES8503372A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN PLASMIDO QUE CONTIENE UNA SECUENCIA DE ADN, DE FORMULA GENERAL (I), A LA QUE, A CONTINUACION DE LA SECUENCIA DE FIJACION A RIBOSOMAS, ESTA INSERTADA UNA SECUENCIA DE ENLAZADOR Y, A CONTINUACION DE LA SECUENCIA DE ENLAZADOR, ESTA INSERTADA LA SECUENCIA DE UN GEN ESTRUCTURAL PARA UN POLIPEPTIDO CUALQUIERA.CONSISTE EN COMBINAR UN VECTOR, POR EJEMPLO, UN PLASMIDO, CON LA CORRESPONDIENTE SECUENCIA DE ADN.
ES533197A 1982-12-24 1984-06-07 Procedimiento para preparar un plasmido Expired ES8503372A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823247922 DE3247922A1 (de) 1982-12-24 1982-12-24 Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten

Publications (2)

Publication Number Publication Date
ES533197A0 ES533197A0 (es) 1985-02-16
ES8503372A1 true ES8503372A1 (es) 1985-02-16

Family

ID=6181687

Family Applications (4)

Application Number Title Priority Date Filing Date
ES528350A Expired ES8501798A1 (es) 1982-12-24 1983-12-23 Procedimiento para la preparacion de interferon humano.
ES533214A Granted ES533214A0 (es) 1982-12-24 1984-06-07 Procedimiento para preparar un plasmido de produccion
ES533213A Expired ES8506090A1 (es) 1982-12-24 1984-06-07 Procedimiento para preparar un plasmido de expresion per 103
ES533197A Expired ES8503372A1 (es) 1982-12-24 1984-06-07 Procedimiento para preparar un plasmido

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES528350A Expired ES8501798A1 (es) 1982-12-24 1983-12-23 Procedimiento para la preparacion de interferon humano.
ES533214A Granted ES533214A0 (es) 1982-12-24 1984-06-07 Procedimiento para preparar un plasmido de produccion
ES533213A Expired ES8506090A1 (es) 1982-12-24 1984-06-07 Procedimiento para preparar un plasmido de expresion per 103

Country Status (19)

Country Link
EP (1) EP0115613B1 (es)
JP (2) JPH088868B2 (es)
KR (1) KR930005455B1 (es)
AT (1) ATE62018T1 (es)
AU (1) AU579991B2 (es)
DD (1) DD216043A5 (es)
DE (2) DE3247922A1 (es)
DK (1) DK576983A (es)
ES (4) ES8501798A1 (es)
FI (1) FI86991C (es)
GR (1) GR78766B (es)
HU (1) HU202277B (es)
IL (1) IL70523A (es)
MX (1) MX9202878A (es)
NO (1) NO173742C (es)
NZ (1) NZ206700A (es)
SU (2) SU1366064A3 (es)
UA (1) UA8035A1 (es)
ZA (1) ZA839519B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584198D1 (de) * 1984-08-01 1991-10-31 Boehringer Ingelheim Int Neue genetische sequenzen, die durch sie codierten interferon-peptide vom typ i und diese sie produzierende organismen.
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
HU204563B (en) * 1984-12-06 1992-01-28 Synergen Biolog Inc Process for producing recombinant serine-protease inhibitors and dns sequencyes for them
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DK156072C (da) * 1985-04-03 1989-11-06 Nordisk Gentofte Syntetisk dna-sekvens indeholdende et ribosombindingssted
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
DE3514113A1 (de) * 1985-04-19 1986-10-23 Hoechst Ag, 6230 Frankfurt Veraenderung der dna-sequenz zwischen shine-dalgarno-sequenz und startcodon des trp-operons zur steigerung der proteinexpression
US4874703A (en) * 1985-08-26 1989-10-17 Eli Lilly And Company Expression vectors for use in E. coli
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
WO1990005186A1 (en) * 1988-11-04 1990-05-17 The Upjohn Company Somatotropin expression using a serratia promoter
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of interferon -alpha/beta binding protein
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US5531880A (en) * 1994-09-13 1996-07-02 Microelectronics And Computer Technology Corporation Method for producing thin, uniform powder phosphor for display screens
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
DE3247923A1 (de) * 1982-12-24 1984-06-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue oligonucleotide und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS59162888A (ja) 1984-09-13
KR840007105A (ko) 1984-12-05
EP0115613A2 (de) 1984-08-15
DE3382233D1 (de) 1991-05-02
ES533213A0 (es) 1985-06-16
HU202277B (en) 1991-02-28
ES8506090A1 (es) 1985-06-16
IL70523A0 (en) 1984-03-30
NZ206700A (en) 1987-11-27
ES533197A0 (es) 1985-02-16
GR78766B (es) 1984-10-02
ES8504930A1 (es) 1985-04-16
SU1417800A3 (ru) 1988-08-15
NO173742C (no) 1994-01-26
NO173742B (no) 1993-10-18
JPH05214000A (ja) 1993-08-24
DK576983A (da) 1984-06-25
FI86991B (fi) 1992-07-31
UA8035A1 (uk) 1995-12-26
SU1366064A3 (ru) 1988-01-07
JPH088868B2 (ja) 1996-01-31
NO834792L (no) 1984-06-25
ES528350A0 (es) 1984-12-01
DK576983D0 (da) 1983-12-14
DE3247922A1 (de) 1984-06-28
ES8501798A1 (es) 1984-12-01
FI834700L (fi) 1984-06-25
DD216043A5 (de) 1984-11-28
EP0115613B1 (de) 1991-03-27
MX9202878A (es) 1992-06-30
AU2283283A (en) 1984-06-28
ES533214A0 (es) 1985-04-16
FI86991C (fi) 1992-11-10
EP0115613A3 (en) 1986-07-23
FI834700A0 (fi) 1983-12-21
JP2637328B2 (ja) 1997-08-06
AU579991B2 (en) 1988-12-22
ZA839519B (en) 1985-08-28
ATE62018T1 (de) 1991-04-15
KR930005455B1 (ko) 1993-06-22
IL70523A (en) 1991-08-16

Similar Documents

Publication Publication Date Title
ES8506090A1 (es) Procedimiento para preparar un plasmido de expresion per 103
JPS5777654A (en) Nonglycosylated interferon
ES8307297A1 (es) Proceso para la produccion microbiana de interferon fibro- blasto humano
KR870001310A (ko) 인체 i형 인터페론 펩타이드의 제조방법
EP0256424B1 (en) Homogeneous recombinant immune interferon fragments and pharmaceutical compositions containing same
Masai et al. Initiation of lagging-strand synthesis for pBR322 plasmid DNA replication in vitro is dependent on primosomal protein i encoded by dnaT.
YU48371B (sh) Plazmidi njihovo dobijanje i njihova upotreba pri dobijanju jednog plazminogenaktivatora
AU9026691A (en) New human recombinant gamma interferon
ZA957750B (en) Process for producing recombinant proteins plasmids and modified cells
DE3586473D1 (de) Den lambda pl-promotor enthaltende plasmide sowie technisch hergestellte restriktionsstelle zum einfachen ersatz einer ribosomalen bindungsstelle, die plasmide enthaltende wirte und entsprechende verfahren.
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
ES8205427A1 (es) Procedimiento para la preparacion de un microorganismo que forma un polipetido con secuencias de aminoacidos de la pro- insulina de primates.
HUT52552A (en) Process for production of negf
Mashko et al. Use of a dual-origin temperature-controlled amplifiable replicon for optimization of human interleukin-1β synthesis in Escherichia coli
Munson TRANSCRIPTION AND TRANSLATION INITIATION IN ESCHERICHIA COLI.
Seth SYNTHESIS AND USE OF DEOXYOLIGORIBONUCLEOTIDES FOR THE STUDY OF SPECIFIC INITIATION OF PROTEIN SYNTHESIS AND EXPRESSION OF EUKARYOTIC GENES IN BACTERIA.
Remaut et al. Expression of heterologous unfused protein in Escherichia coli
NO910331L (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
Muto Control of ribosomal RNA synthesis in Escherichia coli: V. Stimulation of rrnC gene transcription in vitro by a protein factor
NL8203351A (nl) Dna-transcriptie promotor; portable promotor; dna en dna-fragmenten; plasmiden en werkwijze voor het maken daarvan; getransformeerde bacterien, in het bijzonder e.coli bacterien; werkwijze voor het produceren van eiwitten.
IT1189104B (it) Vettore plasmidico ad espressione in bacillus utile per il clonaggio del gene strutturale che codifica per l'ormone della crescita umano e procedimento per la produzione di detto ormone

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301